Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study
B Michelsen, EK Kristianslund, J Sexton… - Annals of the …, 2017 - ard.bmj.com
Objective To investigate the predictive value of baseline depression/anxiety on the
likelihood of achieving joint remission in rheumatoid arthritis (RA) and psoriatic arthritis …
likelihood of achieving joint remission in rheumatoid arthritis (RA) and psoriatic arthritis …
Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010
Objectives To investigate whether baseline disease activity levels and responses in patients
with rheumatoid arthritis (RA) changed during the period 2000–2010. Methods Data were …
with rheumatoid arthritis (RA) changed during the period 2000–2010. Methods Data were …
Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with …
B Michelsen, EK Kristianslund, HB Hammer… - Annals of the …, 2017 - ard.bmj.com
Objective To investigate the predictive value of discordance between (1) tender and swollen
joint count and (2) patient's and evaluator's global assessment on remission in patients with …
joint count and (2) patient's and evaluator's global assessment on remission in patients with …
Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian …
B Michelsen, T Uhlig, J Sexton… - Annals of the …, 2018 - ard.bmj.com
Objectives To compare (1) Short Form-36 (SF-36) Physical Component Summary (PCS) and
Mental Component Summary (MCS), scale scores and Short Form-6 dimensions (SF-6D) …
Mental Component Summary (MCS), scale scores and Short Form-6 dimensions (SF-6D) …
Four-year follow-up of inflammatory arthropathy patients treated with golimumab: Data from the observational multicentre NOR-DMARD study
B Michelsen, J Sexton, A Wierød, G Bakland… - Seminars in Arthritis and …, 2020 - Elsevier
Objective To compare (1) golimumab drug survival and efficacy in bDMARD naïve
compared with non-naïve rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial …
compared with non-naïve rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial …
Is there a role for sulphasalazine in axial spondyloarthritis in the era of TNF inhibition? Data from the NOR-DMARD longitudinal observational study
KM Fagerli, D van der Heijde, MS Heiberg… - …, 2014 - academic.oup.com
Objectives. The objectives of this study were to characterize patients with predominantly
axial SpA who received SSZ as their first DMARD, compare the response to treatment in …
axial SpA who received SSZ as their first DMARD, compare the response to treatment in …
Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data …
JE Gehin, DJ Warren, SW Syversen, E Lie… - Scandinavian Journal …, 2021 - Taylor & Francis
Objectives: This study aimed to identify the therapeutic target concentration and frequency of
anti-drug antibodies (ADAbs) in golimumab-treated patients with inflammatory joint disease …
anti-drug antibodies (ADAbs) in golimumab-treated patients with inflammatory joint disease …
Comparative effectiveness and persistence of SB4 and reference etanercept in patients with psoriatic arthritis in Norway
K Łosińska, AH Pripp, G Bakland… - Arthritis Care & …, 2024 - Wiley Online Library
Objective We aim to compare drug effectiveness and persistence between reference
etanercept (ETN) and ETN biosimilar SB4 in psoriatic arthritis (PsA) patients naïve to ETN …
etanercept (ETN) and ETN biosimilar SB4 in psoriatic arthritis (PsA) patients naïve to ETN …
Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD …
V Norvang, J Sexton, EK Kristianslund, IC Olsen… - RMD open, 2018 - rmdopen.bmj.com
Objective When initiating a new therapy in patients with rheumatoid arthritis (RA), current
treatment recommendations suggest escalating therapy in case of poor clinical improvement …
treatment recommendations suggest escalating therapy in case of poor clinical improvement …
Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD)
P Mielnik, J Sexton, KM Fagerli… - … Advances in Practice, 2023 - academic.oup.com
Abstract Objectives MTX, LEF and SSZ are conventional synthetic DMARDs (csDMARDs)
with a well-established role in the treatment of RA. We aimed to estimate and compare the …
with a well-established role in the treatment of RA. We aimed to estimate and compare the …